Diabetic nerve pain, or neuropathy, is caused by nerve damage due to high blood glucose levels. The precise pathology is unknown but it is estimated that diabetic nerve pain affects 16 percent of the more than 25 million people living with diabetes in the United States. The condition is often unreported and more often untreated, with an estimated two out of five cases not receiving care. The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain, the burning or tingling pain in the hands and feet that affects millions of people with diabetes. The guideline is published in this month’s online issue of Neurology®, the medical journal of the American Academy of Neurology, and was presented at the American Academy of Neurology’s Annual Meeting in Honolulu. This guideline was developed in collaboration with the American Association of Neuromuscular and Electrodiagnostic Medicine and the American Academy of Physical Medicine and Rehabilitation. The recommendations of this guideline will serve as the foundation for a new set of tools the AAN is creating for doctors to measure the quality of care they provide people with nerve pain. The measures will be released in 2012.